Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (7791)
All Articles published online
|
Publishing Process of This Article
|
Oct 21, 2016 (publication date) through Dec 2, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Ilan Y, Ben Ya'acov A, Shabbat Y, Gingis-Velitski S, Almon E, Shaaltiel Y. Oral administration of a non-absorbable plant cell-expressed recombinant anti-TNF fusion protein induces immunomodulatory effects and alleviates nonalcoholic steatohepatitis. World J Gastroenterol 2016; 22(39): 8760-8769 [PMID: 27818591 DOI: 10.3748/wjg.v22.i39.8760] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i39/8760.htm |
| Number | Citing Articles |
| 1 |
Ariel Kenig, Tal Keidar-Haran, Henny Azmanov, Asa Kessler, Yotam Kolben, Tamar Tayri-Wilk, Nir Kalisman, Sarah Weksler-Zangen, Yaron Ilan. Low-Dose Colchicine Attenuates Sepsis-Induced Liver Injury: A Novel Method for Alleviating Systemic Inflammation. Inflammation 2023; 46(3): 963 doi: 10.1007/s10753-023-01783-9
|
| 2 |
Yaron Ilan. Immune rebalancing by oral immunotherapy: A novel method for getting the immune system back on track. Journal of Leukocyte Biology 2019; 105(3): 463 doi: 10.1002/JLB.5RU0718-276RR
|
| 3 |
Mariabeatrice Principi, Andrea Iannone, Giuseppe Losurdo, Michela Mangia, Endrit Shahini, Francesca Albano, Salvatore Fabio Rizzi, Rosa Federica La Fortezza, Rosa Lovero, Antonella Contaldo, Michele Barone, Gioacchino Leandro, Enzo Ierardi, Alfredo Di Leo. Nonalcoholic Fatty Liver Disease in Inflammatory Bowel Disease: Prevalence and Risk Factors. Inflammatory Bowel Diseases 2018; 24(7): 1589 doi: 10.1093/ibd/izy051
|
| 4 |
Tahel Ilan-Ber, Yaron Ilan. The role of microtubules in the immune system and as potential targets for gut-based immunotherapy. Molecular Immunology 2019; 111: 73 doi: 10.1016/j.molimm.2019.04.014
|
| 5 |
Tawfik Khoury, Dory Rotnemer-Golinkin, Lidya Zolotarev, Yaron Ilan. Orally administered anti-eotaxin-1 monoclonal antibody is biologically active in the gut and alleviates immune-mediated hepatitis: A novel anti-inflammatory personalized therapeutic approach. International Journal of Immunopathology and Pharmacology 2021; 35 doi: 10.1177/20587384211021215
|
| 6 |
Sijia Lu, Yibing Wang, Junli Liu. Tumor necrosis factor-α signaling in nonalcoholic steatohepatitis and targeted therapies. Journal of Genetics and Genomics 2022; 49(4): 269 doi: 10.1016/j.jgg.2021.09.009
|
| 7 |
Jia Liu, Mingning Ding, Jinzhao Bai, Ranyi Luo, Runping Liu, Jiaorong Qu, Xiaojiaoyang Li. Decoding the role of immune T cells: A new territory for improvement of metabolic‐associated fatty liver disease. iMeta 2023; 2(1) doi: 10.1002/imt2.76
|
| 8 |
Yaron Ilan. Microtubules as a potential platform for energy transfer in biological systems: a target for implementing individualized, dynamic variability patterns to improve organ function. Molecular and Cellular Biochemistry 2023; 478(2): 375 doi: 10.1007/s11010-022-04513-1
|
| 9 |
Einat Almon, Yoseph Shaaltiel, Wisam Sbeit, Alex Fich, Doron Schwartz, Mattitiahu Waterman, Mali Szlaifer, Hadar Reuveni, Bat-chen Amit-Cohen, Sari Alon, Raul Chertkoff, Alona Paz, Yaron Ilan. Novel Orally Administered Recombinant Anti-TNF Alpha Fusion Protein for the Treatment of Ulcerative Colitis. Journal of Clinical Gastroenterology 2021; 55(2): 134 doi: 10.1097/MCG.0000000000001314
|
| 10 |
Xin Zhong, Minling Lv, MengQing Ma, Qi Huang, Rui Hu, Jing Li, Jinyu Yi, Jialing Sun, Xiaozhou Zhou. State of CD8+ T cells in progression from nonalcoholic steatohepatitis to hepatocellular carcinoma: From pathogenesis to immunotherapy. Biomedicine & Pharmacotherapy 2023; 165: 115131 doi: 10.1016/j.biopha.2023.115131
|
| 11 |
David J. Brayden. Localised Delivery of Macromolecules to the Large Intestine: Translation to Clinical Trials. BioDrugs 2022; 36(6): 687 doi: 10.1007/s40259-022-00562-6
|
| 12 |
Yuval Ishay, Assaf Potruch, Asaf Schwartz, Marc Berg, Khurram Jamil, Samuel Agus, Yaron Ilan. A digital health platform for assisting the diagnosis and monitoring of COVID-19 progression: An adjuvant approach for augmenting the antiviral response and mitigating the immune-mediated target organ damage. Biomedicine & Pharmacotherapy 2021; 143: 112228 doi: 10.1016/j.biopha.2021.112228
|
| 13 |
Xinyu Gu, Qingfei Chu, Xiao Ma, Jing Wang, Chao Chen, Jun Guan, Yanli Ren, Shanshan Wu, Haihong Zhu. New insights into iNKT cells and their roles in liver diseases. Frontiers in Immunology 2022; 13 doi: 10.3389/fimmu.2022.1035950
|
| 14 |
Hao Wu, Yalan Lei, Jingwei Mao. Non-alcoholic fatty liver disease and intestinal immune status: a narrative review. Scandinavian Journal of Gastroenterology 2022; : 1 doi: 10.1080/00365521.2022.2032320
|
| 15 |
Ilio Vitale, Federico Pietrocola, Emma Guilbaud, Stuart A. Aaronson, John M. Abrams, Dieter Adam, Massimiliano Agostini, Patrizia Agostinis, Emad S. Alnemri, Lucia Altucci, Ivano Amelio, David W. Andrews, Rami I. Aqeilan, Eli Arama, Eric H. Baehrecke, Siddharth Balachandran, Daniele Bano, Nickolai A. Barlev, Jiri Bartek, Nicolas G. Bazan, Christoph Becker, Francesca Bernassola, Mathieu J. M. Bertrand, Marco E. Bianchi, Mikhail V. Blagosklonny, J. Magarian Blander, Giovanni Blandino, Klas Blomgren, Christoph Borner, Carl D. Bortner, Pierluigi Bove, Patricia Boya, Catherine Brenner, Petr Broz, Thomas Brunner, Rune Busk Damgaard, George A. Calin, Michelangelo Campanella, Eleonora Candi, Michele Carbone, Didac Carmona-Gutierrez, Francesco Cecconi, Francis K. -M. Chan, Guo-Qiang Chen, Quan Chen, Youhai H. Chen, Emily H. Cheng, Jerry E. Chipuk, John A. Cidlowski, Aaron Ciechanover, Gennaro Ciliberto, Marcus Conrad, Juan R. Cubillos-Ruiz, Peter E. Czabotar, Vincenzo D’Angiolella, Mads Daugaard, Ted M. Dawson, Valina L. Dawson, Ruggero De Maria, Bart De Strooper, Klaus-Michael Debatin, Ralph J. Deberardinis, Alexei Degterev, Giannino Del Sal, Mohanish Deshmukh, Francesco Di Virgilio, Marc Diederich, Scott J. Dixon, Brian D. Dynlacht, Wafik S. El-Deiry, John W. Elrod, Kurt Engeland, Gian Maria Fimia, Claudia Galassi, Carlo Ganini, Ana J. Garcia-Saez, Abhishek D. Garg, Carmen Garrido, Evripidis Gavathiotis, Motti Gerlic, Sourav Ghosh, Douglas R. Green, Lloyd A. Greene, Hinrich Gronemeyer, Georg Häcker, György Hajnóczky, J. Marie Hardwick, Ygal Haupt, Sudan He, David M. Heery, Michael O. Hengartner, Claudio Hetz, David A. Hildeman, Hidenori Ichijo, Satoshi Inoue, Marja Jäättelä, Ana Janic, Bertrand Joseph, Philipp J. Jost, Thirumala-Devi Kanneganti, Michael Karin, Hamid Kashkar, Thomas Kaufmann, Gemma L. Kelly, Oliver Kepp, Adi Kimchi, Richard N. Kitsis, Daniel J. Klionsky, Ruth Kluck, Dmitri V. Krysko, Dagmar Kulms, Sharad Kumar, Sergio Lavandero, Inna N. Lavrik, John J. Lemasters, Gianmaria Liccardi, Andreas Linkermann, Stuart A. Lipton, Richard A. Lockshin, Carlos López-Otín, Tom Luedde, Marion MacFarlane, Frank Madeo, Walter Malorni, Gwenola Manic, Roberto Mantovani, Saverio Marchi, Jean-Christophe Marine, Seamus J. Martin, Jean-Claude Martinou, Pier G. Mastroberardino, Jan Paul Medema, Patrick Mehlen, Pascal Meier, Gerry Melino, Sonia Melino, Edward A. Miao, Ute M. Moll, Cristina Muñoz-Pinedo, Daniel J. Murphy, Maria Victoria Niklison-Chirou, Flavia Novelli, Gabriel Núñez, Andrew Oberst, Dimitry Ofengeim, Joseph T. Opferman, Moshe Oren, Michele Pagano, Theocharis Panaretakis, Manolis Pasparakis, Josef M. Penninger, Francesca Pentimalli, David M. Pereira, Shazib Pervaiz, Marcus E. Peter, Paolo Pinton, Giovanni Porta, Jochen H. M. Prehn, Hamsa Puthalakath, Gabriel A. Rabinovich, Krishnaraj Rajalingam, Kodi S. Ravichandran, Markus Rehm, Jean-Ehrland Ricci, Rosario Rizzuto, Nirmal Robinson, Cecilia M. P. Rodrigues, Barak Rotblat, Carla V. Rothlin, David C. Rubinsztein, Thomas Rudel, Alessandro Rufini, Kevin M. Ryan, Kristopher A. Sarosiek, Akira Sawa, Emre Sayan, Kate Schroder, Luca Scorrano, Federico Sesti, Feng Shao, Yufang Shi, Giuseppe S. Sica, John Silke, Hans-Uwe Simon, Antonella Sistigu, Anastasis Stephanou, Brent R. Stockwell, Flavie Strapazzon, Andreas Strasser, Liming Sun, Erwei Sun, Qiang Sun, Gyorgy Szabadkai, Stephen W. G. Tait, Daolin Tang, Nektarios Tavernarakis, Carol M. Troy, Boris Turk, Nicoletta Urbano, Peter Vandenabeele, Tom Vanden Berghe, Matthew G. Vander Heiden, Jacqueline L. Vanderluit, Alexei Verkhratsky, Andreas Villunger, Silvia von Karstedt, Anne K. Voss, Karen H. Vousden, Domagoj Vucic, Daniela Vuri, Erwin F. Wagner, Henning Walczak, David Wallach, Ruoning Wang, Ying Wang, Achim Weber, Will Wood, Takahiro Yamazaki, Huang-Tian Yang, Zahra Zakeri, Joanna E. Zawacka-Pankau, Lin Zhang, Haibing Zhang, Boris Zhivotovsky, Wenzhao Zhou, Mauro Piacentini, Guido Kroemer, Lorenzo Galluzzi. Apoptotic cell death in disease—Current understanding of the NCCD 2023. Cell Death & Differentiation 2023; 30(5): 1097 doi: 10.1038/s41418-023-01153-w
|
| 16 |
Yuval Ishay, Assaf Potruch, Sarah Weksler‐Zangen, Yehudit Shabat, Yaron Ilan.
Augmented antiviral T cell immunity by oral administration of
IMM‐124E
in preclinical models and a phase I/
IIa
clinical trial: A method for the prevention and treatment of
COVID
‐19
. Drug Development Research 2021; doi: 10.1002/ddr.21890
|
| 17 |
Piotr Eder, Aleksandra Zielińska, Jacek Karczewski, Agnieszka Dobrowolska, Ryszard Słomski, Eliana B. Souto. How could nanobiotechnology improve treatment outcomes of anti-TNF-α therapy in inflammatory bowel disease? Current knowledge, future directions. Journal of Nanobiotechnology 2021; 19(1) doi: 10.1186/s12951-021-01090-1
|
| 18 |
Apostolis Papaefthymiou, Spyros Potamianos, Antonis Goulas, Michael Doulberis, Jannis Kountouras, Stergios A Polyzos. Inflammatory Bowel Disease-associated Fatty Liver Disease: the Potential Effect of Biologic Agents. Journal of Crohn's and Colitis 2022; 16(5): 852 doi: 10.1093/ecco-jcc/jjab212
|